New drug to treat rare leukemia and lymphoma.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000627:therapeutic use*; D002648:Child; D017277:Drug Approval; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D011355:Prodrugs / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001087:Arabinonucleosides; D011355:Prodrugs; C104457:nelarabine